What is the latest chlamydia and gonorrhea news — and what does it mean for sexual health in Europe?

Chlamydia and gonorrhea are among the most commonly reported sexually transmitted infections (STIs) across Europe. In this episode, we explain recent trends, rising case numbers, antibiotic resistance concerns, and what doctors look for during STI assessment.

You’ll learn:

• Current epidemiology of chlamydia and gonorrhea in Europe

• Why testing rates and asymptomatic infections affect reported case numbers

• Symptoms: discharge, painful urination, pelvic pain, testicular discomfort — and why many cases have no symptoms

• The importance of early detection to prevent complications such as pelvic inflammatory disease (PID) or infertility

• How antibiotic resistance, particularly in gonorrhea, is influencing treatment protocols

• When STI testing (urine test, swab, blood test) is recommended after clinical review

• Situations where antibiotic requests may be declined without confirmed diagnosis

We also discuss partner notification, retesting guidance, and safer sex practices.

This episode complements our full clinical guide:

Chlamydia And Gonorrhea News

https://www.mobidoctor.eu/blog/chlamydia-and-gonorrhea-news

Mobi Doctor provides online medical consultations across Europe. Testing and treatment decisions are based on individual risk assessment and established clinical guidelines.